![Glenn Noronha](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Glenn Noronha
Corporate Officer/Principal at
The Association for Research in Vision & Ophthalmology
Profile
Glenn Noronha is a professional with a doctorate degree from Loyola University of Chicago.
He is currently a member of The Association for Research in Vision & Ophthalmology.
In the past, he held positions such as Associate Director-Medicinal Chemistry at TargeGen, Project Head-Global Retinal Development at Alcon Laboratories, Vice President-Research & Development at Sucampo Pharma Americas, and Chief Scientific Officer at Clearside Biomedical, Theriac Pharma Corp., JW Therapeutics (Shanghai) Co., Ltd., Navire Pharma, Inc., and BridgeBio Pharma, Inc. He was also a Research Scientist & Project Leader at Medtronic MiniMed, Inc. from 2000 to 2002.
He will be the Chief Development Officer at PYC Therapeutics Ltd. from 2021 to 2023.
Glenn Noronha active positions
| Companies | Position | Start |
|---|---|---|
The Association for Research in Vision & Ophthalmology
 The Association for Research in Vision & Ophthalmology Miscellaneous Commercial ServicesCommercial Services Operates association for research in vision and ophthalmology | Corporate Officer/Principal | - |
Former positions of Glenn Noronha
| Companies | Position | End |
|---|---|---|
| PYC THERAPEUTICS LIMITED | Corporate Officer/Principal | 2022-12-31 |
| CLEARSIDE BIOMEDICAL | Chief Tech/Sci/R&D Officer | 2018-11-30 |
Sucampo Pharma Americas, Inc. | Chief Tech/Sci/R&D Officer | 2013-04-30 |
Theriac Pharma Corp. | Chief Tech/Sci/R&D Officer | 2012-06-30 |
Alcon Laboratories, Inc.
 Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Operates as an eye care device company | Corporate Officer/Principal | 2010-12-31 |
Training of Glenn Noronha
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
48
1st degree connections
12
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 12 |
|---|---|
TargeGen, Inc.
 TargeGen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures vascular biopharmaceutical products | Health Technology |
Alcon Laboratories, Inc.
Alcon Laboratories, Inc. Medical SpecialtiesHealth Technology Operates as an eye care device company | Health Technology |
Loyola University of Chicago
 Loyola University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
PYC Therapeutics Ltd.
 PYC Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Provides discovery and development of peptide based therapeutic candidates | Health Technology |
Medtronic MiniMed, Inc.
 Medtronic MiniMed, Inc. Medical SpecialtiesHealth Technology Manufactures insulin pumps and glucose monitoring systems | Health Technology |
The Association for Research in Vision & Ophthalmology
The Association for Research in Vision & Ophthalmology Miscellaneous Commercial ServicesCommercial Services Operates association for research in vision and ophthalmology | Commercial Services |
Sucampo Pharma Americas, Inc. | |
Clearside Biomedical, Inc.
 Clearside Biomedical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures suprachoroidal space injections for eye diseases | Health Technology |
Theriac Pharma Corp. | |
JW Therapeutics (Shanghai) Co., Ltd.
 JW Therapeutics (Shanghai) Co., Ltd. BiotechnologyHealth Technology Develops cell-based immunotherapies to treat cancer | Health Technology |
Navire Pharma, Inc.
 Navire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops biopharmaceuticals | Health Technology |
BridgeBio Pharma, Inc.
 BridgeBio Pharma, Inc. BiotechnologyHealth Technology Develops medicines for genetic diseases to patients | Health Technology |
- Stock Market
- Insiders
- Glenn Noronha
